entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 19:26:37 - browse：6114

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Trump's false claims about Georgia's 2020 election long debunked

WSS

Beware the threat of staffing cuts at the CDC

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Multiple sclerosis has subtypes with different best treatments: study

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Patient advocates sound warning on FDA proposal on salt intake

Evacuations in place as 3 wildfires burn in eastern Washington state

focus

entertainment

Sign up for D.C. Diagnosis

focus

Jerome Adams on the need for new antivirals for Covid

Cancer drug shortages' outsize impact on ovarian cancer patients

Hepatitis C has a cure — but many Americans still lack access to it

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Medicare details structure of new drug price negotiation program

Covid silver lining: Unprecedented look at human immune system

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Ukraine taking heavy casualties 10 weeks into its counteroffensive

As demand for Covid shots wanes, Moderna seeks its next success

Trump cancels press conference intended to dispute Georgia election interference charges

knowledge

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Hundreds died while taking an arthritis drug, but nobody alerted patients

FDA approves first treatment for ultra

Gut bacteria may contribute to kidney autoimmunity, study finds

U.K. decision on ALS drug has neurologists, advocates up in arms

As Maui death toll rises, number of missing remains unclear

focus

entertainment

knowledge

knowledge